← Back
$LIXT All transactions

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Aug 18

Insider

Name

Sawyer Jason David

Title

CIK

0002076325

Roles

Director

Transaction Details

Transaction Date

2025-08-15

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Footnotes

Effective August 15, 2025, the reporting person was granted stock options to purchase 25,000 shares vesting 50% on the effective date, the remaining 50% vesting 12.5% on December 31, 2025 and on the last day of each subsequent calendar quarter until fully vested, subject to continuous service. The grant was in connection with the reporting person being appointed to the Company's Board of Directors. The exercise price is $3.59 per share.

Filing Info

Accession No.

0001641172-25-024587

Form Type

4

Issuer CIK

0001335105

Sawyer Jason David's History

Date Ticker Type Value
2026-04-15 LIXT A
2026-04-15 LIXT D
2025-12-22 GRDX A $0
2025-08-15 LIXT A $0

Other Insiders at LIXT (90d)

Insider Bought Sold Last
Felix Lourdes 2026-04-15
Pursglove Geordan Garrett
CEO and Chairman of the Board
2026-04-15
Sawyer Jason David 2026-04-15
Holloway Michael Andrew 2026-04-15
Stazzone Peter
Chief Financial Officer
2026-04-15
Primus Guy Warren 2026-04-15